Hemispherx Ampligen Advisory Cmte. Will Be Early Test Of FDA Focus On Chronic Fatigue Syndrome
This article was originally published in The Pink Sheet Daily
Executive Summary
Ampligen has a shot at becoming the first drug approved for chronic fatigue syndrome, with an advisory panel tentatively slated for Dec. 20. FDA recently unveiled plans to encourage drug development for this condition.